S Kulkarni
About
S Kulkarni is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, S Kulkarni has authored 32 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 16 papers in Oncology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in S Kulkarni's work include Hematopoietic Stem Cell Transplantation (17 papers), Multiple Myeloma Research and Treatments (15 papers) and Acute Lymphoblastic Leukemia research (8 papers). S Kulkarni is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Multiple Myeloma Research and Treatments (15 papers) and Acute Lymphoblastic Leukemia research (8 papers). S Kulkarni collaborates with scholars based in United Kingdom, United States and India. S Kulkarni's co-authors include Seema Singhal, Jayesh Mehta, R Powles, Bhawna Sirohi, J Treleaven, Radovan Sašo, C Horton, J Treleaven, R Powles and B. C. Millar and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.
In The Last Decade
S Kulkarni
32 papers receiving 793 citations
Peers
S Kulkarni
Jennifer Treleaven United Kingdom
Pamela Bartels United States
Howard R. Terebelo United States
E. Winton United States
Anne‐Marie Stoppa France
Antònia Sampol Spain
Peter Bojko Germany
Bradley Augustson Australia
Anne M. Sproul United Kingdom
Catherine Flynn Ireland
Citations per year, relative to S Kulkarni S Kulkarni (= 1×)
peers
Jennifer Treleaven
Countries citing papers authored by S Kulkarni
Since
Specialization
Citations
This map shows the geographic impact of S Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Kulkarni more than expected).
Fields of papers citing papers by S Kulkarni
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by S Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Kulkarni. The network helps show where S Kulkarni may publish in the future.
Co-authorship network of co-authors of S Kulkarni
This figure shows the co-authorship network connecting the top 25 collaborators of S Kulkarni. A scholar is included among the top collaborators of S Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Kulkarni. S Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Hiwarkar, Prashant, Bronwen E. Shaw, J. Michael Tredger, et al.. (2010). Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin. Clinical Transplantation. 25(2). 222–227.
2.
Sirohi, Bhawna, R Powles, J Treleaven, et al.. (2008). The role of maintenance chemotherapy after autotransplantation for acute lymphoblastic leukemia in first remission: single-center experience of 100 patients. Bone Marrow Transplantation. 42(2). 105–112.
3.
Sirohi, Bhawna, R Powles, Dana J. Lawrence, et al.. (2007). An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-α2b in patients with multiple myeloma maintained on a steady dose of interferon-α2b. Annals of Oncology. 18(8). 1388–1394.
4.
Mehta, Jayesh, R Powles, Bhawna Sirohi, et al.. (2004). High-dose melphalan and autotransplantation followed by post transplant maintenance chemotherapy for acute lymphoblastic leukemia in first remission. Bone Marrow Transplantation. 33(11). 1107–1114.
5.
Mehta, Jayesh, R Powles, Bhawna Sirohi, et al.. (2003). Impact of cytogenetics on the outcome of autotransplantation for acute myeloid leukemia in first remission: is the benefit of intensive pretransplant therapy limited to patients with good karyotypes?. Bone Marrow Transplantation. 32(2). 157–164.
6.
Singhal, Seema, P. Jean Henslee‐Downey, R Powles, et al.. (2003). Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission. Bone Marrow Transplantation. 31(10). 889–895.
7.
Mehta, Jayesh, R Powles, Bhawna Sirohi, et al.. (2002). Does donor–recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?. Bone Marrow Transplantation. 29(10). 853–859.
8.
Singhal, Seema, R Powles, P. Jean Henslee‐Downey, et al.. (2002). Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia. Bone Marrow Transplantation. 29(4). 291–295.
9.
Singhal, Seema, R Powles, Bhawna Sirohi, et al.. (2002). Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma. Bone Marrow Transplantation. 30(10). 673–679.
10.
Sirohi, Bhawna, R Powles, S Kulkarni, et al.. (2001). Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria. Bone Marrow Transplantation. 28(1). 29–37.
11.
Sirohi, Bhawna, R Powles, S Kulkarni, et al.. (2001). Glomerular filtration rate prior to high-dose melphalan 200 mg/m2as a surrogate marker of outcome in patients with myeloma. British Journal of Cancer. 85(3). 325–332.
12.
Singhal, Seema, R Powles, J Treleaven, et al.. (2000). A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold?. Bone Marrow Transplantation. 26(5). 489–496.
13.
Kulkarni, S, R Powles, J Treleaven, et al.. (2000). Melphalan/TBI is not more carcinogenic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years. Bone Marrow Transplantation. 25(4). 365–370.
14.
Sirohi, Bhawna, R Powles, J Treleaven, et al.. (2000). The role of autologous transplantation in patients with multiple myeloma aged 65 years and over. Bone Marrow Transplantation. 25(5). 533–539.
15.
Singhal, Seema, R Powles, S Kulkarni, et al.. (2000). Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation. Bone Marrow Transplantation. 25(5). 501–505.
16.
Powles, R, Bhawna Sirohi, S Kulkarni, et al.. (2000). Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma – a phase I/II feasibility and tolerance study of 17 patients. Bone Marrow Transplantation. 25(9). 949–956.
17.
Singhal, Seema, R Powles, J Treleaven, et al.. (1999). Long-term outcome of adult acute leukemia patients who are alive and well 2 years after autologous blood or marrow transplantation. Bone Marrow Transplantation. 23(9). 875–879.
18.
Powles, R, Noopur Raje, S Milan, et al.. (1997). Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment. Bone Marrow Transplantation. 20(6). 435–443.
19.
Raje, Noopur, R Powles, C Horton, et al.. (1997). Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma. British Journal of Cancer. 75(11). 1684–1689.
20.
Treleaven, J, R Powles, S Kulkarni, et al.. (1996). Autografting with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia.. Blood. 88. 1009–1009.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jennifer Treleaven Breakdown of academic impact, for papers by Pamela Bartels Breakdown of academic impact, for papers by Howard R. Terebelo Breakdown of academic impact, for papers by E. Winton Breakdown of academic impact, for papers by Anne‐Marie Stoppa Breakdown of academic impact, for papers by Antònia Sampol Breakdown of academic impact, for papers by Peter Bojko Breakdown of academic impact, for papers by Bradley Augustson Breakdown of academic impact, for papers by Anne M. Sproul Breakdown of academic impact, for papers by Catherine Flynn